To asses effects of mini dose suxamethonium to facilitate laryngeal mask airway (LMA)
insertion and its post operative complications.
Patients and Methods
Sixty ASA 1 and 2 patients aged 15-55 years who were scheduled for various surgical
procedures were divided in two groups. Thirty patients received propofol (control group)
and thirty received suxamethonium 0.1 mgkg as a single bolus dose (study group). Total
dose of propofol, fasciculations, apnea, conditions during LMA insertion and
hemodynamic changes were recorded.
LMA insertion was easy with lesser swallowing, gagging or coughing in group B. Less
amount of propofol was required in group B, hence reduced side effects of propofol were
observed in this group. Myalgia was present in 10% patients given suxamethonium.
The combination of propofol with mini dose suxamethonium provided a significantly
better and economical method for LMA insertion. (Rawal Med J 2010;35: ).
Mini dose suxamethonium, LMA, propofol.
Assessment of structural brain changes in patients with type 2 diabetes mellitus using the MRI-based brain atrophy and lesion index.
Zhao H, Wang F, Luo GH, Lei H, Peng F, Ren QP, Chen W, Wu YF, Yin LC, Liu JC, Pan SN
Neural regeneration research. 2022; 17(3): 618-624
A low dose cell therapy system for treating osteoarthritis: study and mechanistic investigations.
Wang B, Liu W, Li JJ, Chai S, Xing D, Yu H, Zhang Y, Yan W, Xu Z, Zhao B, Du Y, Jiang Q
Bioactive materials. 2022; 7(): 478-490
Baseline Working Memory Predicted Response to Low-Dose Ketamine Infusion in Patients with Treatment-Resistant Depression.
Chen MH, Lin WC, Li CT, Tsai SJ, Wu HJ, Bai YM, Hong CJ, Tu PC, Su TP
Pharmacopsychiatry. 2021; ():
Drug detection in decomposed cadavers confirms testimonial evidence in a case of serial homicides.
Ottaviano V, Tavone AM, Scipione C, Potenza S, Petroni G, Marella GL
Forensic science international. 2021; 325(): 110893
A randomized, double blind, single dose, comparative study of the pharmacokinetics, safety and immunogenicity of MB02 (bevacizumab biosimilar) and reference bevacizumab in healthy male volunteers.
Sinn A, Garcia-Alvarado F, Gonzalez V, Huerga C, Bullo F
British journal of clinical pharmacology. 2021; ():